EFFICACY AND SAFETY OF RADIUM-223 AND STANDARD OF CARE IN PATIENTS WITH BREAST CANCER AND BONE METASTASIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Summary: Radium-223 (Ra-223) has been used to treat metastatic bone disease in prostate cancer, improving overall survival and quality of life. Breast cancer often presents bone metastasis too, but it is often associated with other sites of disease. In such cases, the addition of Ra-223 to the stand...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-04-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137924001949 |